Share the post "IPO Launch: Astec Lifesciences’s OTB on 12-12-2024!"
An IPO, or Initial Public Offering, is when a private company issues shares to the public for the first time, allowing it to raise capital from a diverse pool of investors. This significant step provides the company with the necessary funding to expand and develop while giving early investors a chance to liquidate their holdings. The IPO process typically involves collaboration with investment banks and adherence to strict regulatory standards. Astec Lifesciences IPO of OTB type offers an equity issue (inclusive of premium) with a face value of ₹ 10.00. The issue is live from 12 Dec 2024 to 26 Dec 2024 , with a market lot of 1 shares. This call notice includes , covering ₹10.00 towards face value and the remaining towards securities premium. This is a chance to invest in a well-established company known for its quality and innovation.
| Security Name | ASTEC LIFESCIENCES LIMITED |
|---|---|
| Offer Price () | 1094.96 |
| Face Value | 10.00 |
| Type Of Issue | OTB |
| Issue Status | Forthcoming |
| Scripname | ASTEC LIFESCIENCES LIMITED |
| Security Type | Equity |
| Symbol | ASTEC |
| Issue Type | Takeover |
| Issue Period | 12 Dec 2024 to 26 Dec 2024 |
| Tick Price | 0.01 |
| Market Lot | 1 |
| Book Size – No. Of Shares | 50,99,035 |
| Minimum Offer Quantity | 1 |
| Maximum Offer Quantity | 50,99,035 |
| Floor Price/Offer Price | 1,094.96 |
| Indicative Price | |
| Cummulative Bid Quantity | – |
| Name Of Acquirer(s)/Company | Mr. Nadir Godrej (“Acquirer 1”) Ms. Tanya Dubash (“Acquirer 2”) Ms. Nisaba Godrej (“Acquirer 3”) Mr. Pirojsha Godrej (“Acquirer 4”) Along with Mr. Adi Godrej (“PAC 1”) Ms. Rati Godrej (“PAC 2”) Ms. Karla Bookman (“PAC 3”) Mr. Burjis Godrej (“PAC 4”) Mr. Sohrab Godrej (“PAC 5”) Mr. Hormazd Godrej (“PAC 6”) Mr. Azaar Dubash (“PAC 7”) Mr. Aryaan Dubash (“PAC 8”) Ms. Sasha Godrej (“PAC 9”) Ms. Lana Godrej (“PAC 10”) Mr. Zoran Mehta (“PAC 11”) Ms. Aidan Mehta (“PAC 12”) ABG Family Trust (“PAC 13”) TAD Family Trust (“PAC 14”) TAD Children Trust (“PAC 15”) NG Family Trust (“PAC 16”) NG Children Trust (“PAC 17”) PG Family Trust (“PAC 18”) PG Children Trust (“PAC 19”) PG Lineage Trust (“PAC 20”) NBG Family Trust (“PAC 21”) RNG Family Trust (“PAC 22”) BNG Family Trust (“PAC 23”) BNG Successor Trust (“PAC 24”) BNG Lineage Trust (“PAC 25”) SNG Family Trust (“PAC 26”) SNG Successor Trust (“PAC 27”) SNG Lineage Trust (“PAC 28”) HNG Family Trust (“PAC 29”) and AREL Enterprise LLP (“PAC 30”) (Collectively referred to as the “PACs”) |
| Buyer Member | Kotak Securities Limited |
| Book Running Lead Manager | Kotak Mahindra Capital Company Limited |
| Registrar | BIGSHARE SERVICES PRIVATE LTD |
| Exchange Notices | 1) Opening of Offer to Buy – Acquisition Window (Takeover) of Astec LifeSciences Limited2) Settlement Schedule Offer to Buy – Acquisition Window (Takeover) for ASTEC LIFESCIENCES LIMITED. |
Astec Lifesciences IPO opens on 12-12-2024, and closes on 26-12-2024
| Start Date | 12-12-2024 |
|---|---|
| End Date | 26-12-2024 |
| Issue Period | 12 Dec 2024 to 26 Dec 2024 |
Here are more informative data links:
